Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 8, 1999, Pages 856-863

  Blackwell, Jerry L ^a   Miller, C Ryan ^a   Douglas, Joanne T ^a   Li, Hui ^a   Reynolds, Paul N ^a   Carroll, William R ^b   Peters, Glenn E ^b   Strong, Theresa V ^a   Curiel, David T ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0032781072     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.8.856     Document Type: Article

References (31)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993;328:184-194.
3. Sewell DA, Li D, Duan L, Westra WH, O'Malley BW Jr. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg. 1997;123:1298-1302.
4. Goebel EA, Davidson BL, Zabner J, Graham SM, Kern JA. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol. 1996;105:562-567.
5. Mobley SR, Liu TJ, Hudson JM, Clayman GL. In vitro growth suppression by adenoviral transaction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg. 1998;124:88-92.
6. Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res. 1997;57:4205-4209.
7. Pirollo KF, Hao Z, Rait A, et al. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogens. 1997;14:1735-1746.
8. O'Malley BW, Cope KA, Chen SH, Li D, Schwarta MR, Woo SL. Combination gene therapy for oral cancer in a murine model. Cancer Res. 1996;56:1737-1741.
9. O'Malley BW Jr, Chen SH, Schwartz MR, Woo SL. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 1995;55:1080-1085.
10. Clayman GL, Liu TJ, Overholt SM, et al. Gene therapy for head and neck cancer: comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/ CIP1 (p21). Arch Otolaryngol Head Neck Surg. 1996;122:489-493.
11. Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998;16:2221-2232.
12. He Y, Zeng Q, Drenning SD, et al. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the 16 promoter. J Natl Cancer Inst. 1998;90:1080-1087.
13. Sterman DH, Treat J, Litzky LA, et al. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther. 1998;9:1083-1092.
14. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320-1323.
15. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B Coxsackieviruses. Proc Natl Acad Sci U S A. 1997;94:3352-3356.
16. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
17. Bai M, Harfe B, Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol. 1993;67:5198-5205.
18. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol. 1996;14: 1574-1578.
19. Goldman CK, Rogers BE, Douglas JT, et al. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 1997;57: 1447-1451.
20. Watkins SJ, Mesyanzhinov VV, Kurochkina LP, Hawkins RE. The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 1997;4:1004-1012.
21. Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 1998;58:5738-5748.
22. Kawamoto T, Takahashi K, Nishi M, Kimura T, Matsumura T, Taniguchi S. Quantitative assay of epidermal growth factor receptor in human squamous cell carcinomas of the oral region by an avidin-biotin method. Jpn J Cancer Res. 1991; 82:403-410.
23. Stanton P, Richards S, Reeves J, et al. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer. 1994;70:427-433.
24. Grandis JR, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 1996;78:1284-1292.
25. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993;53:3579-3584.
26. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A. 1993;90:2812-2816.
27. Graham F, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, Walker JM, eds. Molecular Biology, Gene Transfer and Expression Techniques. Totowa, NJ: Humana Press Inc; 1991:109-128.
28. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL. A monoclonal antibody specific for the cellular receptor for the group B Coxsackieviruses. J Virol. 1988;62: 1647-1652.
29. Murthy U, Basu A, Rodeck U, Herlyn M, Ross AH, Das M. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys. 1987;252:549-560.
30. Grandis JR, Tweardy DJ. TGF-alpha and EGFR in head and neck cancer. J Cell Biochem Suppl. 1993;17F:188-191.
31. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995;333:823-831.